Ensign Peak Advisors, Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1454984 SALT LAKE CITY, UT

Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$325,878,000

+$88,208,069 QoQ

Shares Held

2,338,222

+20.8% QoQ

Ownership

0.188%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Ensign Peak Advisors, Inc holds $2,592,331,857 across 12 Drug Manufacturers - General names. GILD ranks #3 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	848,203	$780,151,673
2	JNJ	Johnson & Johnson	1,965,769	$480,512,574
3	GILD	Gilead Sciences, Inc. This page	2,338,222	$325,878,000
4	MRK	Merck & Co., Inc.	2,613,009	$314,318,852
5	ABBV	AbbVie Inc.	1,226,870	$266,831,956
6	BMY	Bristol Myers Squibb Co	3,001,221	$182,024,053
7	PFE	Pfizer Inc	4,829,237	$135,604,974
8	AMGN	Amgen Inc	214,379	$75,429,251

All Filings in GILD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$325,878,000	2,338,222	+20.8%	Shares	Sole	2026-05-13
2025-12-31	$237,669,931	1,936,369	-27.1%	Shares	Sole	2026-02-12
2025-09-30	$294,972,732	2,657,412	+15.7%	Shares	Sole	2025-11-13
2025-06-30	$254,746,220	2,297,702	+7.1%	Shares	Sole	2025-08-12
2025-03-31	$240,349,154	2,145,017	+28.5%	Shares	Sole	2025-05-14
2024-12-31	$154,245,984	1,669,871	+3.8%	Shares	Sole	2025-02-14
2024-09-30	$134,931,844	1,609,397	+12.6%	Shares	Sole	2024-11-14
2024-06-30	$98,032,575	1,428,838	-0.3%	Shares	Sole	2024-08-13
2024-03-31	$105,024,238	1,433,778	-51.9%	Shares	Sole	2024-05-14
2023-12-31	$241,356,981	2,979,348	-16.7%	Shares	Sole	2024-02-14
2023-09-30	$268,187,778	3,578,700	-1.7%	Shares	Sole	2023-11-13
2023-06-30	$280,663,969	3,641,676	+1.8%	Shares	Sole	2023-08-14
2023-03-31	$296,673,671	3,575,674	-9.7%	Shares	Sole	2023-05-15
2022-12-31	$339,999,824	3,960,394	-11.7%	Shares	Sole	2023-02-13
2022-09-30	$276,665,399	4,484,769	+66.5%	Shares	Sole	2022-11-14
2022-06-30	$166,529,120	2,694,210	+22.2%	Shares	Sole	2022-08-12
2022-03-31	$131,085,466	2,204,970	+41.8%	Shares	Sole	2022-05-16
2021-12-31	$112,870,938	1,554,482	-21.8%	Shares	Sole	2022-02-11
2021-09-30	$138,793,975	1,987,029	-6.2%	Shares	Sole	2021-11-12
2021-06-30	$145,942,710	2,119,412	+14.7%	Shares	Sole	2021-08-13
2021-03-31	$119,393,131	1,847,333	+17.2%	Shares	Sole	2021-05-12
2020-12-31	$91,835,937	1,576,312	+49.2%	Shares	Sole	2021-02-12
2020-09-30	$66,766,174	1,056,594	-15.8%	Shares	Sole	2020-11-12
2020-06-30	$96,513,074	1,254,394	-16.3%	Shares	Sole	2020-08-12
2020-03-31	$112,040,943	1,498,675	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.